@article{61a7024d-d2ac-45b0-b226-a50df124290a,
  abstract     = {{<p>Take Home Message Lymph node–positive renal cell carcinoma is a heterogeneous condition. Patients with bulky or multiple nodal metastases often behave like those with metastatic disease and may benefit more from upfront systemic therapy than from surgery alone.</p>}},
  author       = {{Capitanio, Umberto and Zondervan, Patricia and Campi, Riccardo and Kuusk, Teele and Klatte, Tobias and Abu-Ghanem, Yasmin and Bonn, Stephanie and Breen, David J. and Dabestani, Saeed and Hora, Milan and Lund, Lars and Marconi, Lorenzo and Palumbo, Carlotta and Pignot, Geraldine and Tran, Maxine and Woodward, Rose and Suárez, Cristina and Powles, Tom and Bedke, Jens and Bex, Axel}},
  issn         = {{0302-2838}},
  language     = {{eng}},
  publisher    = {{Elsevier}},
  series       = {{European Urology}},
  title        = {{Management of Lymph Node–Positive Renal Cell Carcinoma : Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel}},
  url          = {{http://dx.doi.org/10.1016/j.eururo.2026.04.001}},
  doi          = {{10.1016/j.eururo.2026.04.001}},
  year         = {{2026}},
}